Gene · 3229
HOXC13: homeobox C13
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. HOXC13: homeobox C13. Genes, record 3229. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3229
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P31276 | Homeobox protein Hox-C13 | 330 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents40
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4805378 A1 | 2026-09-16 | 112 | P31276 | Espacenet |
| JP 2026523341 A | 2026-07-14 | 571 | P31276 | Espacenet |
| EP 4771137 A1 | 2026-07-08 | 109 | P31276 | Espacenet |
| EP 4771157 A1 | 2026-07-08 | 109 | P31276 | Espacenet |
| US 12649003 B2 | 2026-06-09 | 571 | P31276 | Espacenet |
| JP 2026510339 A | 2026-04-02 | 109 | P31276 | Espacenet |
| EP 4713451 A2 | 2026-03-25 | 109 | P31276 | Espacenet |
| EP 4713452 A2 | 2026-03-25 | 109 | P31276 | Espacenet |
| US 12558437 B2 | 2026-02-24 | 571 | P31276 | Espacenet |
| EP 4677082 A2 | 2026-01-14 | 109 | P31276 | Espacenet |
1 to 10 of 40
See all 40 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,019
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HOXC13 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 3 | 2025 |
| R01CA097098 | Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer | 3 | 2025 |
| R01DK062370 | Identifying Genes for Type 2 Diabetes: FUSION | 3 | 2025 |
| R01DK075787 | Biological Insights from Genetic Investigation of ANthropometric Traits (GIANT) Across the Allelic Spectrum | 3 | 2025 |
| ZIAHG000024 | Genetic analysis of type II diabetes | 3 | 2025 |
| P01AG036675 | Kynurenine accumulation drives loss of muscle and bone function with aging | 2 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
1 to 10 of 1,019Source NIH's project files
See all 1,019 nih grantsPapers1,422
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL1-mediated m7G modification regulates hair follicle cycle via the HOXC13/FOXN1/DSG4 axis. | PLoS Genet | 2026 | 42771602 | PubTator, text mining | PubMed |
| Ubiquitin-Proteasome System-Related Prognostic Model and Immune Landscape in Glioblastoma. | Int J Genomics | 2026 | 42488132 | PubTator, text mining | PubMed |
| Hoxc13 and homologs of mammalian hair keratins are required for the cornification of nuptial pads in Xenopus frogs. | Commun Biol | 2026 | 42323399 | PubTator, text mining | PubMed |
| HOXC4 Is Associated with the Prognosis and Immune Cell Infiltration in the Progression of Prostate Cancer. | Curr Gene Ther | 2026 | 42227542 | PubTator, text mining | PubMed |
| Injectable polysaccharide-based hydrogel delivering Poria cocos extracellular vesicles promotes hair regeneration in androgenetic alopecia via Wnt/β-catenin signaling. | Int J Biol Macromol | 2026 | 42142777 | PubTator, text mining | PubMed |
| New Cyclopeptides and Curvularins from Marine-Derived Fungal-Bacterial Symbiont Aspergillus spelaeus GXIMD 04541/Sphingomonas echinoides GXIMD 04532. | Mar Drugs | 2026 | 41892970 | PubTator, text mining | PubMed |
| A 7-gene expression signature predicts immune microenvironment remodeling and neoadjuvant chemo-immunotherapy response in lung squamous cell carcinoma. | Front Immunol | 2026 | 41836378 | PubTator, text mining | PubMed |
| Androgen Signaling Represses Homeobox C9, an Inhibitor of Androgen Receptor, in Prostate Cancer Cells. | Int J Mol Sci | 2026 | 41752098 | PubTator, text mining | PubMed |
| Integrative transcriptomic and machine learning analysis identifies CDH17 and HOXC13 as robust candidate prognostic biomarkers in uveal melanoma. | Comput Biol Med | 2026 | 41740484 | PubTator, text mining | PubMed |
| Pure Hair-Nail Ectodermal Dysplasia: Expanding the HOXC13 Genotypic Spectrum. | Pediatr Dermatol | 2026 | 41714886 | PubTator, text mining | PubMed |
1 to 10 of 1,422
See all 1,422 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3229
GET https://conductscience.org/api/genes/v1/3229/patents?page=2